A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.
about
RNA sequencing reveals a slow to fast muscle fiber type transition after olanzapine infusion in ratsAn evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapineChronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin ResistanceMetabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.The pharmacokinetic and safety profiles of blonanserin in healthy Chinese volunteers after single fasting doses and single and multiple postprandial doses.Antipsychotic Maintenance Treatment: Time to Rethink?Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender.Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.Olanzapine as a cause of urinary incontinence: a case reportAcute Metabolic Effects of Olanzapine Depend on Dose and Injection Site.Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitroAntipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.Obesity and Serious Mental Ill Health: A Critical Review of the Literature.Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.Misclassification in assessment of diabetogenic risk using electronic health records.H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice.Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice.Atypical antipsychotics and diabetic ketoacidosis: a review.Genetics of antipsychotic-induced weight gain: update and current perspectives.Acute hyperglycemia associated with short-term use of atypical antipsychotic medications.Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.Antipsychotic-induced metabolic effects in the female rat: Direct comparison between long-acting injections of risperidone and olanzapine.Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report.Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta-analysis.The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies.Metabolic Response to Olanzapine in Healthy Chinese Subjects with rs7093146 Polymorphism in Transcription Factor 7-like 2 Gene (TCF7L2): A Prospective Study.Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
P2860
Q27309270-53DD28C3-3347-487D-9DE8-A50739006947Q28543222-EF391B6C-9D5B-4619-9D7F-018DE07D8D77Q28555023-EA05B921-840E-446C-AD1A-4140C68A8CFCQ30459096-B8B955E0-B82B-45F1-9EB8-0AAD4BFFBB1BQ34376884-3619D145-B7E6-4052-882F-1B11B763CE5DQ34396345-F579DF6F-DD39-42A4-A4C1-E901C5013FFCQ34488215-A45D4E30-0155-495C-A505-D22FECDBF5E3Q35075344-7EA49089-338C-4506-820E-834C4795AAC2Q36063735-9862706A-E18A-4E20-8BAB-F9805EF495E2Q36370778-191BF067-9646-4759-B1F3-8839D8752AB5Q36371905-F5112C4C-DB9E-446A-857C-679E007651CAQ36658341-AC153A5E-5B7B-4703-B2ED-82AF90C2051AQ36852489-A718E733-F859-438A-A800-9FF53F5517ACQ37069133-F0B34C3A-3E59-4FFF-B517-B83937B6D357Q37110540-AFF8AD99-3EA5-45BF-8C4F-13B4AE82948DQ37233836-C4D55B5D-FB82-4C56-9A5D-0D580C7EEB0EQ37273493-9850AA47-99D5-4014-BF44-E2EC08956021Q37598227-F1934841-BD16-4AEB-8B55-7EC041095D16Q38076320-1BFD0105-5744-4E88-AE10-29D826319254Q38166456-74123107-9C18-4178-9BA5-8C12B8C4D0E5Q38176569-4DE7C01D-E3AA-438A-9D8A-3E156B849EDFQ38749335-55118C4B-FEB2-46A0-8258-3978425A3C66Q43943107-11D3C425-6EA5-4EC6-AEE6-5A610B179063Q46254583-0A0A73CE-8FEB-41EA-A8C2-6C56942B60A0Q46668444-951B88E6-ACA4-41A4-B3AD-CC4C98201888Q47121019-BFD47ABE-7F64-4225-8F40-7EFE4989BCFDQ47165661-442B66ED-7621-4A36-BBD2-EE4829E56A4EQ47605999-6E9C1B15-FDED-4BBE-9CA7-21466B40D13EQ49481418-BB7B3EB2-0F5E-42A1-846F-EB4CC4615ECCQ50079662-1995C94D-6FFB-4A5A-A55F-5AA822579656Q51256806-BB1B40AF-BDC8-4AFE-A4F1-5D6938F65DD0Q54662194-B92E5851-00EB-4B61-BEF7-2CF6FC4AE0BEQ55479566-7A8A6262-049E-46DB-9FEA-8D2CBE65C76B
P2860
A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A double blind, placebo-contro ...... nzapine in healthy volunteers.
@ast
A double blind, placebo-contro ...... nzapine in healthy volunteers.
@en
type
label
A double blind, placebo-contro ...... nzapine in healthy volunteers.
@ast
A double blind, placebo-contro ...... nzapine in healthy volunteers.
@en
prefLabel
A double blind, placebo-contro ...... nzapine in healthy volunteers.
@ast
A double blind, placebo-contro ...... nzapine in healthy volunteers.
@en
P2860
P1433
P1476
A double blind, placebo-contro ...... anzapine in healthy volunteers
@en
P2093
David Mauger
Ravi Singareddy
P2860
P304
P356
10.1371/JOURNAL.PONE.0022662
P407
P577
2011-08-09T00:00:00Z